U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H12O2
Molecular Weight 164.2011
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EUGENOL

SMILES

COC1=CC(CC=C)=CC=C1O

InChI

InChIKey=RRAFCDWBNXTKKO-UHFFFAOYSA-N
InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H3

HIDE SMILES / InChI
Molecular Formula C10H12O2
Molecular Weight 164.2011
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://www.drugs.com/otc/470846/eugenol-toothache-medication.html | http://www.indepthinfo.com/nutrition/eugenol.htm

Eugenol is sometimes called clove oil because it is the active element in cloves. It causes the aromatic smell typical of cloves and because of this property is often found in perfumes. Eugenol’s properties make it a good local antiseptic and analgesic. It is used in dentist offices to make zinc-oxide eugenol paste for temporary fillings. Eugenol also demonstrates antifungal and antimicrobial activity, showing efficacy against Candida albicans biofilms, Listeria monocytogenes and Escherichia coli. Eugenol is further described to induce reactive oxygen species (ROS) production and to scavenge ROS, thus demonstrating prooxidant and antioxidant effects. Also, Eugenol is used as a pesticide.

CNS Activity

CNS Active
3913
Sources: DOI: 10.2174/1573407210602010057

Originator

Kremers, F.
1
Sources: DOI: 10.1002/jlac.19194180105

Approval Year

1921
1467
Targets

Targets

Primary TargetPharmacologyConditionPotency
Modulator
828
Agonist
2678
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8429
DENTEK EUGENOL

Approved Use

For the temporary relief of throbbing, persistent toothache due to cavity.
PubMed

PubMed

TitleDatePubMed
Biotechnological production of vanillin.
2001 Aug
Anthelmintic activity of essential oil of Ocimum sanctum and eugenol.
2001 Aug
The significance of fragrance mix, balsam of Peru, colophony and propolis as screening tools in the detection of fragrance allergy.
2001 Aug
Inhibition of malonaldehyde formation from blood plasma oxidation by aroma extracts and aroma components isolated from clove and eucalyptus.
2001 Dec
The histological effects of four endodontic sealers implanted in the oral mucosa: submucous injection versus implant in polyethylene tubes.
2001 Jul
Effects of eugenol on resin bond strengths to root canal dentin.
2001 Jun
Comparative efficacy of tricaine methanesulfonate and clove oil for use as anesthetics in red pacu (Piaractus brachypomus).
2001 Mar
Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens.
2001 Mar
Characterization of T cell responses to fragrances.
2001 May 1
Spontaneous polymerisation on amphibole asbestos: relevance to asbestos removal.
2001 Nov 7
Glycosides and xanthine oxidase inhibitors from Conyza bonariensis.
2001 Oct
Characterization of phenylpropene O-methyltransferases from sweet basil: facile change of substrate specificity and convergent evolution within a plant O-methyltransferase family.
2002 Feb
Aspergillus flavus dose-response curves to selected natural and synthetic antimicrobials.
2002 Mar
In vitro antifungal activity of several antimicrobial compounds against Penicillium expansum.
2002 May
Phenotypic alterations and IL-1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis.
2002 May
Transcriptional control of monolignol biosynthesis in Pinus taeda: factors affecting monolignol ratios and carbon allocation in phenylpropanoid metabolism.
2002 May 24
Extractives content in cooperage oak wood during natural seasoning and toasting; influence of tree species, geographic location, and single-tree effects.
2002 Oct 9
Adverse reactions associated with the use of eugenol in dentistry.
2002 Sep 14
Patents

Patents

04048236
2
05358861
1
07022664
1
07906549
1
08846721
1
JP2000096078A
2
JP2000344641A
3
JP2001131037A
1
JP2001163715A
1
JP2002003351A
1
JP2002087973A
1
JP2002511777A
414
JP2004359602A
2
JP2004532087A
1
JP2005002130A
2
JP2006081461A
1
JP2007325584A
1
JP2008110951A
2
JP2008266319A
5
JP2008509189A
188
JP2009011320A
2
JP2009531121A
10
JP2542801B2
1
JP3302374B2
1
JP3851351B2
2
JP4140829B2
2
JPH01265042A
3
JPH02196718A
8
JPH03234797A
4
JPH03263481A
4
JPH05236972A
4
JPH05255007A
3
JPH05320032A
2
JPH06178660A
2
JPH07228711A
2
JPH09151253A
1
JPH09154930A
1
JPH09241139A
2
JPH10139637A
2
JPH10155496A
2
JPH11228368A
3
JPS57106697A
1
JPS5865207A
1
JPS61171758A
5
JPS63277612A
1
JPS6372654A
5

Sample Use Guides

In Vivo Use Guide
Rinse tooth with water to remove any food particles from the cavity. Moisten a cotton pellet with 1 or 2 drops of medication and using the tweezer, place in the cavity for approximately 1 minute. Avoid touching tissues other than the tooth cavity . Apply the dose not more than four times daily.
Route of Administration: Dental
In Vitro Use Guide
Eugenol displayed in vitro activity against C. albicans cells within biofilms, when MIC(50) for sessile cells was 500 mg/L. C. albicans adherent cell populations (after 0, 1, 2 and 4 h of adherence) were treated with various concentrations of eugenol (0, 20, 200 and 2,000 mg/L). The extent of subsequent biofilm formation were then assessed with the tetrazolium salt reduction assay. Effect of eugenol on morphogenesis of C. albicans cells was observed by scanning electron microscopy (SEM). The results indicated that the effect of eugenol on adherent cells and subsequent biofilm formation was dependent on the initial adherence time and the concentration of this compound, and that eugenol can inhibit filamentous growth of C. albicans cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:00:36 GMT 2023
Edited
by admin
on Fri Dec 15 15:00:36 GMT 2023
Record UNII
3T8H1794QW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EUGENOL
EP   FCC   FHFI   HSDB   II   INCI   MART.   MI   USP   USP-RS   VANDF   WHO-DD  
INCI  
Official Name English
NSC-209525
Code English
EUGENOL [USP-RS]
Common Name English
FEMA NO. 2467
Code English
PHENOL, 2-METHOXY-4-(2-PROPENYL)-
Systematic Name English
EUGENOL [INCI]
Common Name English
4-Allyl-2-methoxyphenol
Systematic Name English
2-METHOXY-4-(2-PROPEN-1-YL)PHENOL
Systematic Name English
EUGENOL [HSDB]
Common Name English
EUGENOL (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC]
Common Name English
4-ALLYLGUAIACOL
Systematic Name English
EUGENOL (CONSTITUENT OF HOLY BASIL LEAF) [DSC]
Common Name English
BIOXEDA
Brand Name English
EUGENOL [VANDF]
Common Name English
EUGENOL [MART.]
Common Name English
EUGENOL [EP MONOGRAPH]
Common Name English
EUGENOL (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC]
Common Name English
4-ALLYLCATECHOL 2-METHYL ETHER
Common Name English
EUGENOL [IARC]
Common Name English
EUGENOL [FHFI]
Common Name English
Eugenol [WHO-DD]
Common Name English
1-HYDROXY-2-METHOXY-4-ALLYLBENZENE
Systematic Name English
EUGENOL [FCC]
Common Name English
EUGENOL [MI]
Common Name English
DENTOGUM
Common Name English
CARYOPHILLIC ACID
Common Name English
EUGENOL [USP MONOGRAPH]
Common Name English
NSC-8895
Code English
EUGENOL [II]
Common Name English
Classification Tree Code System Code
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION SCCS/1459/11
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
DSLD 2902 (Number of products:13)
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
NCI_THESAURUS C245
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
JECFA EVALUATION EUGENOL
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
NDF-RT N0000185508
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
EPA PESTICIDE CODE 102701
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
Code System Code Type Description
ALANWOOD
eugenol
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
SMS_ID
100000078677
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
EPA CompTox
DTXSID9020617
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
RXCUI
4186
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY RxNorm
NDF-RT
N0000175629
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY Increased Histamine Release [PE]
CHEBI
4917
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
CAS
97-53-0
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
HSDB
210
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
DRUG BANK
DB09086
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
ECHA (EC/EINECS)
202-589-1
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
NDF-RT
N0000184306
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY Cell-mediated Immunity [PE]
DAILYMED
3T8H1794QW
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
PUBCHEM
3314
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
NSC
209525
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
MESH
D005054
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
DRUG CENTRAL
4648
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
JECFA MONOGRAPH
1520
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
RS_ITEM_NUM
1268965
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
NSC
8895
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
FDA UNII
3T8H1794QW
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
EVMPD
SUB13776MIG
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
ChEMBL
CHEMBL42710
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
MERCK INDEX
m5210
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C75095
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
NDF-RT
N0000171131
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY Allergens [Chemical/Ingredient]
WIKIPEDIA
EUGENOL
Created by admin on Fri Dec 15 15:00:36 GMT 2023 , Edited by admin on Fri Dec 15 15:00:36 GMT 2023
PRIMARY
Related Record Type Details
CLOVE OIL
PARENT -> CONSTITUENT ALWAYS PRESENT
ASSAY (GC)
CHINESE CINNAMON LEAF OIL
PARENT -> CONSTITUENT MAY BE PRESENT
CYNARA SCOLYMUS LEAF
PARENT -> CONSTITUENT ALWAYS PRESENT
CINNAMON BARK OIL
PARENT -> CONSTITUENT MAY BE PRESENT
ASSAY (GC)
CHINESE CINNAMON LEAF OIL
PARENT -> CONSTITUENT ALWAYS PRESENT
A cinnamon leaf oil of Chinese origin, Cinnamomun japonicum Sieb., contains a high concentration of safrole (60%) and only about 3% eugenol.
CHINESE CINNAMON
PARENT -> CONSTITUENT ALWAYS PRESENT
USP
GEUM URBANUM WHOLE
PARENT -> CONSTITUENT ALWAYS PRESENT
CINNAMON
PARENT -> CONSTITUENT ALWAYS PRESENT
CINNAMON LEAF OIL
PARENT -> CONSTITUENT ALWAYS PRESENT
ASSAY (GC)
HOLY BASIL LEAF
PARENT -> CONSTITUENT ALWAYS PRESENT
USP
ACORUS CALAMUS ROOT
PARENT -> CONSTITUENT ALWAYS PRESENT
In view of the toxic properties documented for the oil and associated with beta-asarone , it has been recommended that only beta-asarone-free calamus root should be used in phytotherapy.
Related Record Type Details
Structure of EUGENOL
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966